Delivery Order SPE2DB22D9124-SPE2DB24FP4HN

Award Date 2/13/24
Potential Completion Date 3/6/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, with a ceiling value of $8,576.28, is for the delivery of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999 through 2025, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $37,750.80, is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The delivery order was issued under an Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $35,734.50 and a period of performance through August 2, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA,...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,734.96, is for the delivery of NEXPLANON 68 MG IMPLANTS to the DLA. This order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
This is a $12,307.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560 units of the NEXPLANON 68 MG IMPLANTS contraceptive device, with a period of performance through March 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, with a ceiling value of $3,573.45, is for the delivery of NEXPLANON 68 MG IMPLANTS. The contract has no set-aside designation and represents a task order against a larger indefinite delivery vehicle (IDV) contract, contract SPE2DB24FD5KN, held by DMS Pharmaceutical Group with DLA....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,550.16 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized contraceptive product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to order a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. The contract has a potential value of $21,440.70 and a completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery, single-award vehicle contract (4600082013) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the provision of NEXPLANON 68 mg implants, with a ceiling value of $7,146.90 and a period of performance through May 20, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and is responsible for delivering the pharmaceutical products under this delivery order. The contract is not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a total ceiling value of $4,288.14. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2024. This order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with...
  • SPE2DB22D9124
    Indefinite Delivery Contract
  • SPE2DB22D9124-SPE2DB24FP4HN
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has a potential value of $7,146.90. The contract completion date is March 6, 2024. This delivery order is issued under DMS Pharmaceutical Group's broader indefinite delivery contract 4600082013 with the DLA, which has a maximum value of $4,999,999 and enables the agency to place orders for a wide range of pharmaceutical items to support military medical facilities globally. The contract does not have a set-aside designation.

Generated 5/14/24, 1:18 PM